Control of bilirubin production by synthetic heme analogs: pharmacologic and toxicologic considerations.
Drummond
G S
GS
Rockefeller University, New York, NY 10021, USA.
Valaes
T
T
Kappas
A
A
D000818:Animals; D001663:Bilirubin / Q000096:biosynthesis*; D002986:Clinical Trials as Topic; D003345:Corticosterone / Q000096:biosynthesis / Q000097:blood; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000188:drug therapy*; D008297:Male; D008652:Mesoporphyrins / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity*; D011247:Pregnancy; D011270:Pregnancy, Animal; D051381:Rats; D013739:Testosterone / Q000096:biosynthesis / Q000097:blood; D013974:Thyroxine / Q000096:biosynthesis / Q000097:blood; D014284:Triiodothyronine / Q000096:biosynthesis / Q000097:blood
D008652:Mesoporphyrins; D014284:Triiodothyronine; D013739:Testosterone; C031468:mesoporphyrin IX; D013974:Thyroxine; D001663:Bilirubin; D003345:Corticosterone